RECTAL CARCINOMA
Clinical trials for RECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost immune attack on Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a new cancer vaccine (p53MVA) combined with the immunotherapy drug pembrolizumab in people with advanced solid tumors that have not responded to other treatments. The vaccine helps the immune system recognize and attack cancer cells, while pembrolizum…
Matched conditions: RECTAL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
Massive cancer screening trial aims to cut deaths
Prevention OngoingThis study looked at whether regular screening for prostate, lung, colorectal, and ovarian cancers can lower the number of people who die from these diseases. Over 154,000 adults aged 55 to 74 took part. Researchers compared screening to usual care to see if early detection helps…
Matched conditions: RECTAL CARCINOMA
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 19, 2026 11:48 UTC
-
New study tracks hidden side effects of pelvic radiation in women
Knowledge-focused OngoingThis study follows 72 women with pelvic cancers (like cervical, rectal, or anal cancer) who are receiving radiation therapy. Researchers measure physical changes in the vagina and collect surveys about sexual function, intimacy, and quality of life before treatment and up to 2 ye…
Matched conditions: RECTAL CARCINOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:47 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes in a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers (solid tumors, lymphoma, or myeloma) had their tumors genetically screened. Those with specific genetic c…
Matched conditions: RECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC